Lv1
88 积分 2024-09-19 加入
[Chinese expert consensus on the follow-up management of patients with prostate cancer receiving medical castration therapy（2024 edition）]
5天前
已完结
Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
6天前
已完结
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
1个月前
已完结
A phase III multicenter, randomized, controlled study of combined androgen blockade with versus without zoledronic acid in prostate cancer patients with metastatic bone disease: results of the ZAPCA trial
1个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
1个月前
已完结
Response assessment criteria for brain metastases: proposal from the RANO group
1个月前
已完结
Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors
1个月前
已完结
Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study
1个月前
已完结
Tepotinib Treatment in Patients With MET Exon 14–Skipping Non–Small Cell Lung Cancer
1个月前
已完结
The present and future of bispecific antibodies for cancer therapy
1个月前
已完结
皖公网安备34019202002308
